Oncotelic completes $0.5M debt conversion and issues 12 convertible note units

Oncotelic Therapeutics, Inc.

Issued 12 units each with a $25,000 convertible note (convertible at $0.10/share) and warrants to buy 250,000 shares at $0.12/share.
Converted $500,000 of debt from 4 accredited investors under prior private placement into Subscription Agreements.
Paid $45,000 placement agent fees to JH Darbie & Co., which also earned 13% of warrants issued.
This fourth tranche concludes conversion of all notes from prior private placement; company hopes to raise additional funds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.